Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04783077
Other study ID # 326045
Secondary ID UG3HL151599
Status Completed
Phase N/A
First received
Last updated
Start date November 2, 2021
Est. completion date September 25, 2023

Study information

Verified date January 2024
Source University of Minnesota
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

DESIGN This pilot study utilizes a mixed-methods approach to develop a novel docu- drama communication strategy, design WhatsApp intervention, evaluate the feasibility of a larger pragmatic randomized controlled trial (RCT) of the two communication strategies and assess acceptability of the communication strategies aimed to increase blood donation among first-time blood donors within the catchment areas of the Southern Zonal Blood Centre (SZBC) in Ghana. In sequence, this pilot study and larger RCT are grounded in the PRECEDE-PROCEED implementation science framework. The pilot study has four components: 1) a qualitative component will be used to design a docu-drama, 2) key informant interviews to guide intervention development, 3) a simultaneous randomized pilot trial will evaluate the feasibility of the larger trial design of communication interventions using WhatsApp compared to control, and 4) a final mixed- methods (quantitative survey and focus groups) assessment of participant views of acceptability, effectiveness, feasibility and cultural appropriateness of the two proposed communication interventions. OBJECTIVES The three objectives of this pilot study are the careful design of a novel docu- drama communication intervention and WhatsApp intervention, evaluation of the feasibility of a larger RCT of communication strategies, and assessment of participant views of the two proposed communication interventions and control among first time blood donors within the catchment areas of the SZBC. For the purposes of registration for clinicaltrials.gov only the randomized pilot trial communication interventions using WhatsApp compared to control is reported. The planned sample size for the pilot RCT is n=128 first-time blood donors. The study population for the pilot RCT is first-time voluntary non-remunerated blood donors (VNRBD) and family/replacement blood donors (FRD) from the SZBC catchment area. REGIMEN WhatsApp: Participants assigned to the WhatsApp group will receive weekly messages developed by communication specialists aimed to motivate blood donation, be encouraged to discuss their blood donation experiences, and share their own motivations for donating blood in a moderated, closed group over a six-month duration. The moderator will provide guidelines on acceptable use of WhatsApp in the group, including images they can or cannot share. Participants will also receive standard NBSG communications for first-time donors. Control: Participants in this group will receive the standard NBSG communications for first-time donors: 1) a thank you phone call and 2) and a reminder phone call two-weeks prior to the second blood donation eligibility. The second blood donation eligibility is four months after the first donation.


Recruitment information / eligibility

Status Completed
Enrollment 144
Est. completion date September 25, 2023
Est. primary completion date September 25, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - At least 18 years-old - First-time whole blood donor with the SZBC of the NBSG - Eligible to donate again - Consent to participate - Understands one of English, Twi, or Ga - Have a smart phone - Have, or be willing to sign up for an active WhatsApp account Exclusion Criteria: • History of more than one lifetime whole blood donation (with any blood centre)

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
WhatsApp
Participants assigned to the WhatsApp group will receive weekly messages developed by communication specialists aimed to motivate blood donation, be encouraged to discuss their blood donation experiences, and share their own motivations for donating blood in a moderated, closed group over a six-month duration. The moderator will provide guidelines on acceptable use of WhatsApp in the group, including images they can or cannot share. Participants will also receive standard NBSG communications for first-time donors.
Control
Participants in this group will receive the standard NBSG communications for first-time donors: 1) a thank you phone call and 2) and a reminder phone call two-weeks prior to the second blood donation eligibility. The second blood donation eligibility is four months after the first donation.
Docudrama
Participants will be exposed to a document-drama related to blood donation.

Locations

Country Name City State
Ghana National Blood Service Ghana Accra

Sponsors (6)

Lead Sponsor Collaborator
University of Minnesota Liverpool School of Tropical Medicine, National Blood Service Ghana, National Heart, Lung, and Blood Institute (NHLBI), Syracuse University, University of Ghana, College of Health Sciences

Country where clinical trial is conducted

Ghana, 

Outcome

Type Measure Description Time frame Safety issue
Primary Donation Attempt Blood donation attempt at any time during follow-up. The planned follow-up (i.e., ?nal assessment) was at 6-months and 2 weeks from randomization. However, the local protocol IRB approval lapsed between 25 April 2022 and 23 May 2022 during which time participants were unable to receive WhatsApp messaging. In response, the ?nal follow-up window was extended by 34 days for all participants, so the participants in the WhatsApp arm would receive all planned messages. 6 Months and 34 days
See also
  Status Clinical Trial Phase
Completed NCT00097006 - Retrovirus Epidemiology Donor Study-II (REDS-II) N/A
Completed NCT00005721 - Retaining Donors and Increasing Donation Frequency N/A
Recruiting NCT04078893 - The Effect of Recruiting Inactive Blood Donors Using Different Means N/A
Completed NCT02274064 - Motivating Type O- Blood Donors to Return N/A
Completed NCT02717338 - Blood Donor Competence, Autonomy and Relatedness Enhancement Phase 3
Completed NCT01104740 - Dengue Seroprevalence Study in Blood Donors in the French West Indies
Completed NCT03988738 - Promoting Repeat Blood Donation Through Social Media Among First-time Donors in a Peruvian Blood Bank N/A
Completed NCT04088695 - Effect of a Web Page Based on a Motivational Video for Voluntary Blood Donation N/A
Completed NCT00005278 - Retrovirus Epidemiology Donor Study I (REDS I) N/A
Recruiting NCT00001846 - Collection and Distribution of Blood Components From Healthy Donors for In Vitro Research Use
Completed NCT00005339 - Risk of Post Transfusion Hepatitis C Virus Infection N/A
Terminated NCT00005341 - Blood Donation--Immune Sequelae and Recruitment
Completed NCT03835299 - Addressing Fear and Risk of Vasovagal Reactions Among High School Donors N/A
Recruiting NCT06021925 - Obstetrical History and Anti-HLA Antibodies Level
Completed NCT00005360 - HIV Diversity and Pathogenesis in Donor-Recipient Clusters N/A
Completed NCT03102385 - A Survey of Attitudes of Experienced Blood Donors N/A
Completed NCT02145507 - Evaluation of Whole Blood With CPD Anticoagulant and AS-7/SOLX Additive Solution Phase 1
Completed NCT00029406 - Transfusion Infections Pediatric Prospective Study (TRIPPS) N/A
Completed NCT00006310 - KSHV Infection in Blood Donors From Texas N/A